Literature DB >> 21215394

Plasma creatine phosphokinase level may predict successful treatment after a single injection of methotrexate for ectopic pregnancy.

Audrey Gnisci1, Sandrine Rua, Blandine Courbiere, Ludovic Cravello, Marc Gamerre, Aubert Agostini.   

Abstract

Our finding that creatine phosphokinase level was significantly higher in women successfully treated for ectopic pregnancy with only a single injection of methotrexate suggests that this indicator predicts this outcome.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21215394     DOI： 10.1016/j.fertnstert.2010.12.020

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  3 in total

1.  The Role of Plasma Creatine Phosphokinase (CPK) Level in Prediction of Response to Methotrexate for Ectopic Pregnancy.

Authors:  Fatemeh Davari-Tanha; Mohadese Ghazi; Mona Mohseni; Farahnaz Ahmadi
Journal:  J Family Reprod Health       Date:  2016-06

2.  Evaluation of Plasma Creatine Phosphokinase (CPK) Level Following a Single Injection of Methotrexate as a Predicator of Treatment Success in Ectopic Pregnancy.

Authors:  Leila Safdarian; Marzieh Aghahosseini; Ashraf Alleyassin; Mina Kohbodi
Journal:  J Family Reprod Health       Date:  2013-12

3.  Evaluation of serum creatine phosphokinase in diagnosis of tubal ectopic pregnancy compared with intrauterine pregnancy and threatened abortion.

Authors:  Maryam Asgharnia; Roya Faraji; Fariba Mirblouk; Zahra Atrkar Roshan; Ayda Parvizi
Journal:  Iran J Reprod Med       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.